PATUVIGIN Trademark

Trademark Overview

On Tuesday, November 13, 2007, a trademark application was filed for PATUVIGIN with the United States Patent and Trademark Office. The USPTO has given the PATUVIGIN trademark a serial number of 79046402. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, November 14, 2017. This trademark is owned by NOVARTIS AG. The PATUVIGIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology
patuvigin

General Information

Serial Number79046402
Word MarkPATUVIGIN
Filing DateTuesday, November 13, 2007
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, November 14, 2017
Registration Number3468331
Registration DateTuesday, July 15, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 20, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Friday, June 8, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, June 8, 2018DEATH OF INTERNATIONAL REGISTRATION
Monday, January 4, 2016TOTAL INVALIDATION PROCESSED BY THE IB
Friday, December 11, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, December 11, 2015INVALIDATION PROCESSED
Tuesday, October 20, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 20, 2015CANCELLED SECTION 71
Friday, April 12, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 19, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 28, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, November 4, 2008FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, November 4, 2008FINAL DISPOSITION PROCESSED
Friday, October 17, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 15, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, April 29, 2008PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2008NOTICE OF PUBLICATION
Monday, March 24, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 24, 2008ASSIGNED TO LIE
Saturday, March 8, 2008REFUSAL PROCESSED BY IB
Thursday, March 6, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 6, 2008EXAMINER'S AMENDMENT ENTERED
Thursday, March 6, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 6, 2008EXAMINERS AMENDMENT E-MAILED
Thursday, March 6, 2008EXAMINERS AMENDMENT -WRITTEN
Monday, March 3, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 3, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 7, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 7, 2008REFUSAL PROCESSED BY MPU
Thursday, February 7, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 6, 2008NON-FINAL ACTION WRITTEN
Friday, February 1, 2008ASSIGNED TO EXAMINER
Friday, December 14, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, December 13, 2007LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, December 13, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

patuvigin oncology preparations pharmaceutical